Processa Pharmaceuticals, Inc. (PCSA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.59M | -2.9M | -3.48M | -2.27M | -2.73M | -2.25M | -3.6M | -3.35M | -2.05M | -2.12M | -1.76M | -2.06M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -31.53% | -29.05% | 3.28% | 32.14% | -33.24% | -5.83% | -104.58% | -62.07% | 3.08% | 14.96% | 40.8% | 11.42% |
| Net Income | -3.38M | -3.36M | -3.44M | -3.93M | -2.83M | -2.73M | -3.38M | -3.01M | -2.73M | -2.4M | -2.08M | -2.61M |
| Depreciation & Amortization | 301 | 301 | 301 | 301 | 301 | 301 | 203 | 139 | 139 | 140 | 82 | 20.18K |
| Stock-Based Compensation | 95.96K | 0 | 75.34K | 430.96K | 227.71K | 155.05K | 154.19K | 152.63K | 167.64K | 256.82K | 142.89K | 319.12K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -291.78K | 0 | -20.18K |
| Other Non-Cash Items | 59.82K | -171.64K | 252.03K | -204.29K | 22.94K | 22.48K | 22.03K | 21.3K | 21.37K | 312.76K | 20.57K | 20.18K |
| Working Capital Changes | -369.6K | 629.7K | -375.46K | 1.44M | -146.4K | 303.15K | -394.33K | -509.57K | 488.34K | 3.13K | 157.47K | 208.79K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -216.43K | 329.62K | -58.58K | 233.19K | -328.32K | 169.17K | -241.38K | 497.72K | 143.75K | -34.68K | 107.28K | -77.69K |
| Cash from Investing | -500K | -850K | 0 | 0 | 0 | 0 | -3.24K | 0 | 0 | 0 | -2.78K | 0 |
| Capital Expenditures | -500K | -850K | 0 | 0 | 0 | 0 | -3.24K | 0 | 0 | 0 | -2.78K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 244.78K | 2.98M | 2.86M | 6.31M | 4.44M | 547.58K | 926.2K | -3.41K | 6.26M | -30.61K | -52.75K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | -1.31K | -1.54K | -1.46K | -1.44K | -1.41K | -895 | 0 | 0 | 0 |
| Equity Issued (Net) | 245.1K | 2.98M | 2.86M | 6.32M | 4.44M | 549.36K | 927.63K | -2.01K | 6.27M | 22.14K | -52.75K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 1.44K | 0 | -1.44K | -312 | -3.66K | -2.01K | -9.92K | 0 | -52.75K | 0 |
| Other Financing | -320 | 0 | 0 | -8.96K | 0 | -312 | 0 | 0 | -8.56K | -52.75K | 0 | 0 |
| Net Change in Cash | -3.85M | -771.47K | -628.2K | 4.04M | 1.71M | -1.7M | -2.68M | -3.35M | 4.21M | -2.15M | -1.82M | -2.06M |
| Free Cash Flow | -3.59M | -2.9M | -3.48M | -2.27M | -2.73M | -2.25M | -3.61M | -3.35M | -2.05M | -2.12M | -1.76M | -2.06M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -31.53% | -29.05% | 3.37% | 32.14% | -33.24% | -5.83% | -104.45% | -62.07% | 3.08% | 14.96% | 40.7% | 11.42% |
| FCF per Share | -1.37 | -1.13 | -1.83 | -3.65 | -7.16 | -15.20 | -27.52 | -28.04 | -20.77 | -41.29 | -32.66 | -38.32 |
| FCF Conversion (FCF/Net Income) | 1.06x | 0.86x | 1.01x | 0.58x | 0.96x | 0.82x | 1.06x | 1.11x | 0.75x | 0.88x | 0.85x | 0.79x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |